Apyx Medical Corp Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Apyx Medical Corp stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $0.00.
- Apyx Medical Corp stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $88.00K.
- Apyx Medical Corp stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $49.00K.
- Apyx Medical Corp stock issued during period, value, stock options exercised for the quarter ending 2023-12-31 was $0.00.
- Apyx Medical Corp stock issued during period, value, stock options exercised for fiscal 2025 was $488.00K.
- Apyx Medical Corp stock issued during period, value, stock options exercised for fiscal 2023 was $86.00K, a 76.44% decline from fiscal 2022.
- Apyx Medical Corp stock issued during period, value, stock options exercised for fiscal 2022 was $365.00K, a 444.78% increase from fiscal 2021.
- Apyx Medical Corp stock issued during period, value, stock options exercised for fiscal 2021 was $67.00K, a 54.73% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $88.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $488.00K 10-K · filed 2026-03-10 | |
| 2025-09-30 | $49.00K 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $86.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $30.00K 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $56.00K 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $365.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $157.00K 10-Q · filed 2023-11-09 | $383.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $56.00K 10-Q · filed 2023-08-11 | $254.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $152.00K 10-Q · filed 2023-05-11 | $198.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $67.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $28.00K 10-Q · filed 2022-11-10 | $100.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $97.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $21.00K 10-Q · filed 2022-05-12 | $97.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $148.00K 10-K · filed 2021-03-31 |
| 2020-09-30 | $25.00K 10-Q · filed 2021-11-12 | $150.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $164.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $72.00K 10-Q · filed 2021-05-12 | $212.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $207.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $39.00K 10-Q · filed 2020-11-09 | -$2.75M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $48.00K 10-Q · filed 2020-08-10 | -$2.72M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $67.00K 10-Q · filed 2020-05-11 | -$2.69M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$2.90M derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-03-31 | $202.00K 10-K · filed 2020-03-31 |
| 2018-09-30 | $65.00K 10-Q · filed 2019-11-15 | |
| 2018-06-30 | $83.00K 10-Q · filed 2019-08-07 | |
| 2017-12-31 | $152.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2019-03-14 | $427.00K 10-K · filed 2019-03-14 |
| 2016-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $130.00K 10-K · filed 2019-03-14 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $220.00K 10-K · filed 2018-03-13 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $71.00K derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | $209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $281.00K derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-03-31 | $11.00K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | -$149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $232.00K 10-K · filed 2017-03-10 |
| 2014-09-30 | $210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | |
| 2013-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $70.00K 10-K · filed 2015-02-27 |
| 2013-09-30 | $25.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-14 | $74.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $23.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-09-25 | $52.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $23.00K 10-Q · filed 2013-05-15 | $36.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $20.00K 10-K · filed 2015-02-27 |
| 2012-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $26.00K derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $31.00K derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-03-31 | $7.00K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $9.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-05-08 | $39.00K 10-K/A · filed 2014-05-08 |
| 2011-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | |
| 2010-12-31 | $39.00K 10-K · filed 2013-04-01 | |
| 2009-12-31 | $286.00K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |